Every text message, photograph, and saved file still comes down to a simple bargain: information is stored as either 0 or 1.
Cultivated meat startup SuperMeat has raised $6M in fresh financing, as part of a targeted $10M Series A4 round, and filed ...
VTech Holdings Limited (HKSE: 303) today announced its results for the year ended 31 March 2026. "VTech reported a decrease in revenue in the financial year 2026. Changes in US tariff policies and ...
Most of us spend a fortune trying to look younger from the outside: creams, serums, treatments. But if you’re not addressing ...
Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, reprogrammed using CRISPR gene editing to attack tumors more aggressively.
Reached broad alignment with the FDA on the registration path for CRB-701 for 2L treatment in head and neck squamous cell carcinoma (HNSCC) and ...
TAGMO Clinical Readouts -- Initial results for head and neck, and upper GI adenocarcinoma cohorts are expected midyear, with ...
Understanding how near-zero latency, deterministic timing and smart network design redefine the way everything from robots to ...
Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.
Achieved the primary objective with favorable safety and tolerability, no discontinuations and no serious adverse events ---- ...
Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile - - Completion of patie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results